Although many approaches have been tested to overcome the insulin dependence caused by the pancreatic \u3b2-cells destruction observed in individuals affected by type 1 diabetes (T1D), medical research has largely failed to halt the onset or to reverse T1D
Type 1 diabetes is an autoimmune disease, hence the rationale for immunotherapy to halt disease prog...
Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by loss of tolerance towards bet...
T ype 1 diabetes is an autoimmunedisease that causes the body to de-stroy insulin-producing -cells i...
Introduction: Although many approaches have been tested to overcome the insulin dependence caused by...
Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by destruction of insulin-produ...
Recent advances on using immune and stem cells as two-pronged approaches for type 1 diabetes mellitu...
The idea of treating type 1 diabetes mellitus (T1D) with immunosup-pressive agents began with the re...
We strive but struggle to translate immunetherapies that have been shown to be effec-tive in preclin...
Type 1 diabetes mellitus results from immune-mediated destruction of pancreatic β-cells, leading to ...
Recent advances on using immune and stem cells as two-pronged approaches for type 1 diabetes mellitu...
For almost a hundred years, the management of Type 1 diabetes has not advanced beyond insulin replac...
Optimized insulin therapies, increased use of continuous glucose monitoring/insulin pumps and most i...
Type 1 diabetes mellitus (T1DM) affects 1 in 300 people and the incidence of the disease is rising w...
Insulin replacement therapy is considered the only effective and feasible treatment for type 1 diabe...
Despite considerable effort to halt or delay destruction of \u3b2-cells in autoimmune type 1 diabete...
Type 1 diabetes is an autoimmune disease, hence the rationale for immunotherapy to halt disease prog...
Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by loss of tolerance towards bet...
T ype 1 diabetes is an autoimmunedisease that causes the body to de-stroy insulin-producing -cells i...
Introduction: Although many approaches have been tested to overcome the insulin dependence caused by...
Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by destruction of insulin-produ...
Recent advances on using immune and stem cells as two-pronged approaches for type 1 diabetes mellitu...
The idea of treating type 1 diabetes mellitus (T1D) with immunosup-pressive agents began with the re...
We strive but struggle to translate immunetherapies that have been shown to be effec-tive in preclin...
Type 1 diabetes mellitus results from immune-mediated destruction of pancreatic β-cells, leading to ...
Recent advances on using immune and stem cells as two-pronged approaches for type 1 diabetes mellitu...
For almost a hundred years, the management of Type 1 diabetes has not advanced beyond insulin replac...
Optimized insulin therapies, increased use of continuous glucose monitoring/insulin pumps and most i...
Type 1 diabetes mellitus (T1DM) affects 1 in 300 people and the incidence of the disease is rising w...
Insulin replacement therapy is considered the only effective and feasible treatment for type 1 diabe...
Despite considerable effort to halt or delay destruction of \u3b2-cells in autoimmune type 1 diabete...
Type 1 diabetes is an autoimmune disease, hence the rationale for immunotherapy to halt disease prog...
Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by loss of tolerance towards bet...
T ype 1 diabetes is an autoimmunedisease that causes the body to de-stroy insulin-producing -cells i...
DOI
Add to ORKG